Pfizer (PFE) Change in Acquisitions & Divestments (2010 - 2026)

Pfizer (PFE) has 17 years of Change in Acquisitions & Divestments data on file, last reported at $4.6 billion in Q1 2026.

• Change in Acquisitions & Divestments for Q1 2026 came in at $4.6 billion, up 15.7% year-over-year; the trailing twelve-month figure through Mar 2026 was $18.6 billion (up 123.94% YoY), and the FY2025 annual result was $18.0 billion, up 335.05% from the prior year.
• Change in Acquisitions & Divestments retreated to $4.6 billion in Q1 2026 per PFE's latest filing, from $4.7 billion in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $35.1 billion in Q4 2022 and troughed at $658.0 million in Q1 2024.
• A 5-year average of $8.1 billion and a median of $5.4 billion in 2023 frame the typical range for Change in Acquisitions & Divestments.
• The sharpest annual moves came in 2024 and 2025: Change in Acquisitions & Divestments tumbled 89.72% in 2024, then jumped 520.97% in 2025.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $35.1 billion in 2022, then slumped by 39.45% to $21.2 billion in 2023, then slumped by 87.62% to $2.6 billion in 2024, then jumped by 79.58% to $4.7 billion in 2025, then dropped by 3.11% to $4.6 billion in 2026.
• Business Quant data shows PFE's Change in Acquisitions & Divestments at $4.6 billion in Q1 2026, $4.7 billion in Q4 2025, and $2.7 billion in Q3 2025.